AU2002221895A1 - Macrolide solvates - Google Patents

Macrolide solvates

Info

Publication number
AU2002221895A1
AU2002221895A1 AU2002221895A AU2189502A AU2002221895A1 AU 2002221895 A1 AU2002221895 A1 AU 2002221895A1 AU 2002221895 A AU2002221895 A AU 2002221895A AU 2189502 A AU2189502 A AU 2189502A AU 2002221895 A1 AU2002221895 A1 AU 2002221895A1
Authority
AU
Australia
Prior art keywords
macrolide
solvates
macrolide solvates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221895A
Other languages
English (en)
Inventor
Victor Centellas
Jose Diago
Rafael Garcia
Johannes Ludescher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Industrial Products SA
Original Assignee
Biochemie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie SA filed Critical Biochemie SA
Publication of AU2002221895A1 publication Critical patent/AU2002221895A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2002221895A 2000-11-27 2001-11-26 Macrolide solvates Abandoned AU2002221895A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
US60/253,119 2000-11-27
GB0031355.1 2000-12-21
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (1)

Publication Number Publication Date
AU2002221895A1 true AU2002221895A1 (en) 2002-06-03

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221895A Abandoned AU2002221895A1 (en) 2000-11-27 2001-11-26 Macrolide solvates

Country Status (15)

Country Link
US (1) US6949519B2 (cs)
EP (1) EP1339730A2 (cs)
JP (1) JP2004519430A (cs)
KR (1) KR100815163B1 (cs)
AU (1) AU2002221895A1 (cs)
BG (1) BG66200B1 (cs)
CA (1) CA2429639C (cs)
CZ (1) CZ303343B6 (cs)
EE (1) EE05200B1 (cs)
HR (1) HRP20030430B1 (cs)
HU (1) HU229488B1 (cs)
NO (1) NO324951B1 (cs)
PL (1) PL207076B1 (cs)
SK (1) SK287814B6 (cs)
WO (1) WO2002042315A2 (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
JP2004530703A (ja) 2001-05-22 2004-10-07 ファイザー・プロダクツ・インク 結晶形アジスロマイシン
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
EP1606299A1 (en) * 2003-03-25 2005-12-21 Teva Pharmaceutical Industries Ltd. Degradation products of azithromycin, and methods for their identification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
US20120058936A1 (en) 2009-03-13 2012-03-08 Assistance Publique - Hopitaux De Paris Compositions and methods for elimination of gram negative bacteria

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
JP2002531409A (ja) * 1998-11-30 2002-09-24 テバ ファーマシューティカル インダストリーズ リミティド アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤
HRP20010956B1 (hr) * 1999-06-29 2010-09-30 Biochemie S.A. Makrolidi
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
HRP20030430A2 (en) 2005-04-30
NO20032371L (no) 2003-07-10
CZ20031439A3 (cs) 2003-10-15
HUP0302099A2 (hu) 2003-10-28
EE200300255A (et) 2003-08-15
US6949519B2 (en) 2005-09-27
US20040053862A1 (en) 2004-03-18
SK6352003A3 (en) 2003-11-04
HUP0302099A3 (en) 2009-08-28
CZ303343B6 (cs) 2012-08-08
EE05200B1 (et) 2009-08-17
SK287814B6 (sk) 2011-11-04
CA2429639A1 (en) 2002-05-30
NO324951B1 (no) 2008-01-14
PL207076B1 (pl) 2010-10-29
KR20030055305A (ko) 2003-07-02
HRP20030430B1 (hr) 2011-11-30
HU229488B1 (hu) 2014-01-28
NO20032371D0 (no) 2003-05-26
EP1339730A2 (en) 2003-09-03
WO2002042315A3 (en) 2002-10-31
BG107832A (bg) 2004-07-30
WO2002042315A2 (en) 2002-05-30
JP2004519430A (ja) 2004-07-02
BG66200B1 (bg) 2012-01-31
KR100815163B1 (ko) 2008-03-19
PL361276A1 (en) 2004-10-04
CA2429639C (en) 2009-07-14

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
AU2001228708A1 (en) Coin-validation arrangement
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001272719A1 (en) Macrolide antibiotics
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001296577A1 (en) Chlorophyllases
AU2001258349A1 (en) Bisacylguanidine
AU4657001A (en) Displacing arrangement
AU2002221895A1 (en) Macrolide solvates
AU2001279754A1 (en) Indoloquinazolinones
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001258924A1 (en) Microsatellite-aflp
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002230386A1 (en) Sixteen-membered macrolide compounds
AU2001226668A1 (en) Crankshaft-starter-generator
AUPQ673400A0 (en) Keypad
AU2002234567A1 (en) Console
AU2001260192A1 (en) Glycinamides